NCT01451164View on ClinicalTrials.gov

A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

459

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2015

Conditions
Schizophrenia
Interventions
DRUG

OPC-34712

orally administered once daily

DRUG

OPC-34712

orally administered once daily

DRUG

OPC-34712

orally administered once daily

DRUG

Placebo

orally administered once daily

Trial Locations (1)

Unknown

Kanto Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY